Background: Tunnelled pleural catheters used to treat malignant pleural effusions may
achieve pleurodesis. We aimed to identify factors associated with higher pleurodesis rates …

PURPOSE: To evaluate patient outcomes when tunneled pleural drainage catheters are
placed for symptomatic, recurrent malignant pleural effusion following failed chemical …

Background Malignant pleural effusion (MPE) is a common cause of quality of life
deterioration in patients with advanced cancer. Management options include chemical …

Abstract Background: Indwelling pleural catheters (IPCs) are an emerging therapy for
persistent benign pleural effusions. IPCs may achieve pleurodesis and be removed …

Background: Indwelling tunneled pleural catheters (TPCs) are increasingly being used to
treat recurrent pleural effusions. There is also an increased interest in early pleurodesis in …

Background Tunneled pleural catheters (TPCs) are routinely used for outpatient drainage of
malignant pleural effusions, although use in recurrent pleural effusions resulting from …

The aim of the present study was to examine the effectiveness of tunnelled pleural catheters
(TPC) in patients with malignant pleural effusions who would otherwise be candidates for …

Introduction: Malignant pleural effusion can be recurrent despite active anti-cancer
treatment. Significant malignant pleural effusion leads to debilitating dyspnoea and …

Tunneled pleural catheters (TPC), such as the PleurX catheter system, have been shown to
be effective in the management of recurrent malignant pleural effusions (MPEs) for …

Introduction: Despite increasing use of tunneled pleural catheters (TPCs), their efficacy as a
definitive procedure for achieving palliation or spontaneous pleurodesis (SP) in the …